DXCM vs POST · P/E 63, rev $4.03B vs P/E 15, rev $8.16B
DexCom Inc (DXCM) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the DXCM and POST stock pages for the full models.
Not investment advice.